195 related articles for article (PubMed ID: 29997084)
1. [Generation of a new strain of NOD/SCID/IL2Rγ
Liu YC; Chen Q; Yang XL; Tang QS; Yao KT; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):639-646. PubMed ID: 29997084
[TBL] [Abstract][Full Text] [Related]
2. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
3. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
[TBL] [Abstract][Full Text] [Related]
4. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
5. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
[TBL] [Abstract][Full Text] [Related]
6. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.
Bernstein JM; Brooks SP; Lehman HK; Pope L; Sands A; Shultz LD; Bankert RB
Ann Otol Rhinol Laryngol; 2009 Dec; 118(12):866-75. PubMed ID: 20112521
[TBL] [Abstract][Full Text] [Related]
7. Development of Teratocarcinomas and Teratomas in Severely Immunodeficient NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/Szj (NSG) Mice.
Lim CY; Solter D; Knowles BB; Damjanov I
Stem Cells Dev; 2015 Jul; 24(13):1515-20. PubMed ID: 25897827
[TBL] [Abstract][Full Text] [Related]
8. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg
Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P
Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human cord blood engraftment between immunocompromised mouse strains.
McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE
Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133
[TBL] [Abstract][Full Text] [Related]
11. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
[TBL] [Abstract][Full Text] [Related]
12. Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse.
Ippolito GC; Hoi KH; Reddy ST; Carroll SM; Ge X; Rogosch T; Zemlin M; Shultz LD; Ellington AD; Vandenberg CL; Georgiou G
PLoS One; 2012; 7(4):e35497. PubMed ID: 22558161
[TBL] [Abstract][Full Text] [Related]
13. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
Hasgur S; Aryee KE; Shultz LD; Greiner DL; Brehm MA
Methods Mol Biol; 2016; 1438():67-78. PubMed ID: 27150084
[TBL] [Abstract][Full Text] [Related]
14. A humanized mouse model to study human immune response in xenotransplantation.
Ji M; Jin X; Phillips P; Yi S
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):494-8. PubMed ID: 23060394
[TBL] [Abstract][Full Text] [Related]
15. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL
Clin Immunol; 2010 Apr; 135(1):84-98. PubMed ID: 20096637
[TBL] [Abstract][Full Text] [Related]
16. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
[TBL] [Abstract][Full Text] [Related]
17. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M
Leuk Lymphoma; 2015; 56(11):3198-206. PubMed ID: 25827173
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.
Chung YS; Son JK; Choi B; Park JB; Chang J; Kim SJ
Clin Immunol; 2015 Dec; 161(2):308-15. PubMed ID: 26360254
[TBL] [Abstract][Full Text] [Related]
19. Humanized SCID mouse models for biomedical research.
Pearson T; Greiner DL; Shultz LD
Curr Top Microbiol Immunol; 2008; 324():25-51. PubMed ID: 18481451
[TBL] [Abstract][Full Text] [Related]
20. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
